Company · Ownership research

Odyssey Therapeutics, Inc. ODTX

CIK 0001882782

Form 3 statements with an event date from Nov 1, 2023 to Nov 15, 2026.

Insider tradingInitial holdingsInstitutional holders

Some filings are submitted jointly by several insiders. The SEC form does not apportion the reported figures between them, so results include every joint filer.

Where insider ownership starts.

Form 3 is an initial ownership statement filed when someone becomes a reporting insider. These holdings do not mean they bought shares that day.

202619 of 19 statements

Holdings date	Insider	Initial holdings
May 7, 2026	Dimension Capital II, L.P. Director	512.86K shares · 1 derivative holding	▾
May 7, 2026	COULTER JAMES G · WINKELRIED JON · TPG GP A, LLC 10% owner / 10% owner / 10% owner	2 derivative holdings	▾
May 7, 2026	NG CAROLYN Director	0 shares	▾
May 7, 2026	Walbert Timothy P Director	3 derivative holdings	▾
May 7, 2026	Odegard Valerie Director	7 derivative holdings	▾
May 7, 2026	Tatsis Ourania Director	1 derivative holding	▾
May 7, 2026	Chu Shelley Director	No securities reported	▾
May 7, 2026	Dales Natalie See Remarks	36.88K shares · 2 derivative holdings	▾
May 7, 2026	Opipari Anthony W. See Remarks	11 derivative holdings	▾
May 7, 2026	Siegel Jolie See Remarks	1 derivative holding	▾
May 7, 2026	Li Nan (LN) Director	512.86K shares · 1 derivative holding	▾
May 7, 2026	LEIDEN JEFFREY M Director	265.20K shares · 10 derivative holdings	▾
May 7, 2026	George Simeon · SR ONE CAPITAL MANAGEMENT, LLC 10% owner / 10% owner	15 derivative holdings	▾
May 7, 2026	Glick Gary D See Remarks · Director	388.59K shares · 7 derivative holdings	▾
May 7, 2026	Todd Collin M See Remarks	8 derivative holdings	▾
May 7, 2026	SMITH IAN F Director	246.10K shares	▾
May 7, 2026	Haas Jason Chief Financial Officer	61.91K shares · 3 derivative holdings	▾
May 7, 2026	Hill Paulina Director	No securities reported	▾
May 7, 2026	Pavletic Aranicki Ksenija Director	No securities reported	▾

Showing 19 / 19 statements in 2026. The complete set is available through the API.

Odyssey Therapeutics, Inc. · ODTX

Follow the people behind the trades.

Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.

Download CSV
Earlier filings
Advanced screening & filtering
API & AI access

Already have an account?

＋ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For 2026, this page lists 19 of 19 statements.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.

MCP  https://api.akkrudata.ai/mcp

akkru_initial_holdings
{"action":"list","ticker":"ODTX","page_size":20}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint: https://api.akkrudata.ai/mcp
API / MCP / CLI documentation: /documents
llms.txt: /llms.txt

Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.